HBV and HCV co-infections in HIV positive patients in the "HAART era": new challenges

NATALIA L LAUFER; JORGE F QUARLERI; MARÍA B BOUZAS; HÉCTOR M PEREZ; HORACIO SALOMON; PEDRO E CAHN

MEDICINA (BUENOS AIRES)

MEDICINA (BUENOS AIRES)

Año: 2007 vol. 67 p. 82 - 91

0025-7680

Co-infections with HIV and HCV/HBV are frequently found due to the similar routes of transmission (sexual, parenteral and vertical). Since the introduction of highly active antiretroviral therapy (HAART) there has been a notably decrease in patients morbidity and mortality, nevertheless with the prolonged survival, many of these patients are at risk of developing chronic complication, secondary to the infection of hepatotropic viruses. End stage liver disease is one of the main causes of morbid-mortality among HIV patients in developed countries. Nowadays there are new available therapies, diagnostic and follow up techniques for HBV and HCV, what provides a better control of both co-infections.